MetLife Investment Management’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.6M | Sell |
|
|||||
|
2025
Q1 | $17.6M | Buy |
|
|||||
|
2024
Q4 | $1.42M | Buy |
|
|||||
|
2024
Q3 | $1.27M | Sell |
|
|||||
|
2024
Q2 | $1.04M | Buy |
|
|||||
|
2024
Q1 | $909K | Buy |
|
|||||
|
2023
Q4 | $877K | Hold |
|
|||||
|
2023
Q3 | $610K | Hold |
|
|||||
|
2023
Q2 | $702K | Buy |
|
|||||
|
2023
Q1 | $837K | Hold |
|
|||||
|
2022
Q4 | $939K | Sell |
|
|||||
|
2022
Q3 | $681K | Hold |
|
|||||
|
2022
Q2 | $372K | Buy |
|
|||||
|
2022
Q1 | $409K | Buy |
|
|||||
|
2021
Q4 | $239K | Buy |
|
|||||
|
2021
Q3 | $136K | Sell |
|
|||||
|
2021
Q2 | $243K | Hold |
|
|||||
|
2021
Q1 | $195K | Buy |
|
|||||
|
2020
Q4 | $56K | Sell |
|
|||||
|
2020
Q3 | $58.8K | Sell |
|
|||||
|
2020
Q2 | $212K | Hold |
|
|||||
|
2020
Q1 | $176K | Buy |
|
|||||
|
2019
Q4 | $94.9K | Sell |
|
|||||
|
2019
Q3 | $261K | Hold |
|
|||||
|
2019
Q2 | $189K | Hold |
|
|||||
|
2019
Q1 | $251K | Hold |
|
|||||
|
2018
Q4 | $94.5K | Hold |
|
|||||
|
2018
Q3 | $186K | Sell |
|
|||||
|
2018
Q2 | $157K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $144K | Buy |
|